ZIOPHARM Oncology, Inc.
(NASDAQ : ZIOP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
-0.67%342.921.2%$619.87m
GILDGilead Sciences, Inc.
-0.65%72.450.9%$507.42m
CELGCelgene Corporation
-0.42%90.001.2%$494.37m
AMGNAmgen Inc.
-0.06%197.311.2%$485.07m
ILMNIllumina, Inc.
0.28%326.793.5%$374.74m
REGNRegeneron Pharmaceuticals, Inc.
-0.41%372.742.6%$314.50m
VRTXVertex Pharmaceuticals Incorporated
-0.90%174.501.9%$207.20m
ALXNAlexion Pharmaceuticals, Inc.
0.26%116.302.0%$187.07m
AAgilent Technologies, Inc.
0.11%64.731.5%$159.45m
SRPTSarepta Therapeutics, Inc.
-0.29%129.8716.6%$142.04m
NKTRNektar Therapeutics
0.45%60.305.6%$126.86m
BLUEBluebird Bio, Inc.
-0.60%157.0514.6%$120.84m
EXASExact Sciences Corporation
-0.72%48.4925.3%$117.97m
BMRNBioMarin Pharmaceutical Inc.
-2.09%98.904.4%$116.26m
INCYIncyte Corporation
-0.23%68.642.5%$111.47m

Company Profile

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. The company was founded on September 9, 2003 and is headquartered in Boston, MA.